Clinical Trial

A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics, and pharmacodynamics of multiple doses of VIS954 compared with placebo in healthy adult participants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-17; most recent amendment 2026-06-01.
Status change: Active, Not Recruiting → Completed 2026-06-01
Status change: Recruiting → Active, Not Recruiting 2025-08-19
Trial Details
NCT Number NCT06937593
Lead Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Conditions Healthy
Enrollment 24 participants
Start Date 2025-03-13
Primary Completion 2026-02-03 (estimated)
Study Completion 2026-02-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-03